E Fund Management Co., Ltd. Spring Works Therapeutics, Inc. Transaction History
E Fund Management Co., Ltd.
- $1.6 Billion
- Q1 2024
A detailed history of E Fund Management Co., Ltd. transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 8,486 shares of SWTX stock, worth $312,030. This represents 0.03% of its overall portfolio holdings.
Number of Shares
8,486
Previous 7,752
9.47%
Holding current value
$312,030
Previous $282,000
47.87%
% of portfolio
0.03%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding SWTX
# of Institutions
235Shares Held
67.7MCall Options Held
546KPut Options Held
29.4K-
Vanguard Group Inc Valley Forge, PA6.53MShares$240 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.44MShares$200 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.11MShares$151 Million0.02% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.48MShares$128 Million5.66% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$126 Million8.76% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.29B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...